Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05028751
Status:
TERMINATED
Last Update Posted:
2024-04-22
First Post:
2021-08-25
Brief Title:
A Study to Evaluate Lanraplenib LANRA in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia AML
Sponsor:
Kronos Bio
Organization:
Kronos Bio
Organization Data
Organization:
Kronos Bio
Class:
INDUSTRY
Study ID:
KB-LANRA- 1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kronos Bio
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None